Seckinger, A., Hillengaß, J., Emde-Rajaratnam, M., Beck, S., Kimmich, C., Dittrich, T., . . . Hose, D. (2018). CD38 as immunotherapeutic target in light chain amyloidosis and multiple myeloma: Association with molecular entities, risk, survival, and mechanisms of upfront resistance. Frontiers in immunology, 9, . https://doi.org/10.3389/fimmu.2018.01676
Chicago-Zitierstil (17. Ausg.)Seckinger, Anja, et al. "CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma: Association with Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance." Frontiers in Immunology 9 (2018). https://doi.org/10.3389/fimmu.2018.01676.
MLA-Zitierstil (9. Ausg.)Seckinger, Anja, et al. "CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma: Association with Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance." Frontiers in Immunology, vol. 9, 2018, https://doi.org/10.3389/fimmu.2018.01676.